In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging U.S. population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the forecast period, the market will maintain growth at a CAGR in the mid single digits.

Abstract
This report on cardiac rhythm management (CRM) devices analyzes the market for medical devices used
for diagnosing and treating cardiac arrhythmias. The medical device markets included in this report are
pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices
(CRTs), cardiac stimulation leads, electrocardiogram monitoring (ECGs), external defibrillators,
electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation
catheters.